Page last updated: 2024-08-23

idarubicin and Jejunal Diseases

idarubicin has been researched along with Jejunal Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Freireich, EJ; Jendiroba, D; Keyhani, A; Liu, B; Pagliaro, L; Pearlman, M; Travis, E	1
Itoh, R; Mizuno, T; Morita, K; Suzuki, H; Tanaka, I	1

Other Studies

2 other study(ies) available for idarubicin and Jejunal Diseases

Article	Year
Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity. Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Disease Models, Animal; Doxorubicin; Idarubicin; Injections, Intraperitoneal; Jejunal Diseases; Jejunum; Male; Mice; Mice, Inbred C3H; Protective Agents; Razoxane	2003
[Successful emergency operation for massive hemorrhage due to jejunal angiodysplasia after intensive chemotherapy in a patient with refractory anemia with excess of blasts]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:7 Topics: Anemia, Refractory, with Excess of Blasts; Angiodysplasia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Therapy, Combination; Emergencies; Enterocolitis; Gastrointestinal Hemorrhage; Humans; Idarubicin; Jejunal Diseases; Male; Mercaptopurine; Middle Aged; Neutropenia; Prednisolone; Vincristine	1998

Article

Year

Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.

Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:6

Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Disease Models, Animal; Doxorubicin; Idarubicin; Injections, Intraperitoneal; Jejunal Diseases; Jejunum; Male; Mice; Mice, Inbred C3H; Protective Agents; Razoxane

2003

[Successful emergency operation for massive hemorrhage due to jejunal angiodysplasia after intensive chemotherapy in a patient with refractory anemia with excess of blasts].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:7

Topics: Anemia, Refractory, with Excess of Blasts; Angiodysplasia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Therapy, Combination; Emergencies; Enterocolitis; Gastrointestinal Hemorrhage; Humans; Idarubicin; Jejunal Diseases; Male; Mercaptopurine; Middle Aged; Neutropenia; Prednisolone; Vincristine

1998